Market Research Blog – Page 1802 – New Product Development

Anticipated Expansion in Steviacane Market: Expected Valuation of USD 239.0 Million by 2034, Growing at 9.0% CAGR

According to Future Market Insights (FMI) analysis, the steviacane market is expected to reach US$ 101.0 million in 2024 and US$ 239.0 million by 2034. The market is anticipated to expand at a CAGR of 9.0% over the forecast period.

Steviacane is the ideal alternative to traditional sugar, offering a sweet taste with fewer calories. Steviacane is a sugar substitute in several sugar-free food and beverage products, providing them with a similar sweetness without harmful health effects.

Steviacane is developed and designed to taste and look like granulated sugar but has 2/3 fewer calories than sugar. Steviacane can be used in several recipes and is suitable for baking, as it tastes like sugar.

The food & beverage industry has been a significant consumer of steviacane, with manufacturers incorporating it into several products, from sugar-free confectionery and bakery items to beverages and even pharmaceuticals. The versatility of steviacane, coupled with its natural origin, has made it a sought-after ingredient in the food industry.

Request Your Sample Report Today: https://www.futuremarketinsights.com/reports/sample/rep-gb-18694

The global steviacane market is experiencing a significant boom driven by the growing demand for natural and healthier sugar alternatives. Also, the trend of clean-label, organic, and non-GMO products fuels the market growth.

Key Takeaways from the Report:

The global steviacane market is expected to reach a valuation of US$ 239.0 million in 2034.
The market is expected to surge at a CAGR of 9.0% over the forecast period.
The United States is projected to reach a market valuation of US$ 76.5 million in 2034.
The powder form is estimated to hold a market share of 90.0% in 2024.
Germany is projected to reach a market valuation of US$ 26.3 million in 2034.

Competitive Landscape

Imperial Sugar (LDC), PureCircle Ltd., Cargill, Inc., Tate & Lyle PLC, Ingredion Incorporated, GLG Life Tech Corporation, and The Truvía Company, LLC are the leading players operating in the market. Introducing new products enables businesses to remain competitive, meet evolving consumer demands, attract clientele, retain existing customers, and expand their market share.

To hold onto their positions in the market, key firms are expanding their marketing and research & development budgets as well as their distribution networks. In order to create new-generation technology for the production of steviacane products, leading players are using competitive techniques.

For instance,

In July 2022, Sweegen unveiled a brand-new line of liquid stevia called Bestevia LQ.
In March 2022, Cargill revealed its plan to use EverSweet + ClearFlo technology to sweeten its stevia products commercially.
In July 2021, Layn invested US$ 148 million to construct a new stevia plant to help fulfill the growing demand for natural sweeteners worldwide.

Maximize Growth Potential Grab Your Report Today: https://www.futuremarketinsights.com/checkout/18694
Key Companies Profiled

Imperial Sugar (LDC)
PureCircle Ltd.
Cargill, Inc.
Tate & Lyle PLC
Ingredion Incorporated
GLG Life Tech Corporation
The Truvía Company, LLC
In The Raw

Global Steviacane Market Segmentation by Category

By Form:

Powder
Liquid

By Application:

Dairy Products
Bakery Products
Beverages
Confectionery Products
Dietary Supplements
Snacks
Table Top Sweeteners
Others (Electrolyte Mixes and Medicinal Formulations)

By Nature:

Organic
Conventional

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Dry Eye Syndrome Treatment Market Projected to Reach USD9.5 Billion by 2033, at a CAGR of 6.4% | FMI Study

According to a recent analysis, the Dry Eye Syndrome Treatment Market is estimated to reach USD 9.521 million by 2033, reflecting a Compound Annual Growth Rate (CAGR) of 6.4% over the forecast period. This surge from a market value of USD 5.12 billion in 2023 highlights the growing demand for effective solutions to manage this prevalent condition.

The rising prevalence of dry eye syndrome, combined with rising demand for dry eye treatment to alleviate various symptoms, is a major factor driving the growth of the Dry Eye Syndrome Treatment market.

Request a Sample of this Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-1215

Dry eye disease (DED) has developed as a public health concern, causing ocular discomfort, fatigue, and visual disturbance that reduces quality of life. It is one of the most common and troublesome ocular surface disorders (OSDs).

It happens when tears are unable to provide adequate moisture/lubrication or are produced insufficiently. This illness can cause a number of symptoms, including redness, a burning sensation, and inflammation, as well as itching and blurred vision.

Dry Eye Syndrome Treatment Market Key Takeaways:

In 2022, the United States accounted for 80.6% of the North American dry eye syndrome therapy market.
Germany owned around 17.2% of the European dry eye syndrome therapy market in 2022.
The artificial tears category will grow at a 7.1% CAGR depending on the product type.
Hospital pharmacies will continue to dominate the market in terms of distribution channel over the evaluation period.

Dry Eye Syndrome Treatment Market Competitive Landscape

In a competitive environment, prominent market players are focusing on increasing research and development efforts to develop new products with long-lasting attributes and greater efficiency. These organizations vigorously engage in product launches, agreements, and approvals to enhance their market footprints. In the recent timeline, that is between 2019 and 2021, many businesses have actively sought product approval and concentrated on releasing novel products. For instance, in October 2021, Tyrvaya nasal spray for dry eye was approved by the US Food and Drug Administration (FDA). Other developments include the October 2019 announcement of Sun Pharmaceutical Industries Ltd., that one of its subsidiaries had commercialized CEQUA (cyclosporine ophthalmic solution) 0.09% in the US.

Avail Discount
https://www.futuremarketinsights.com/request-discount/rep-gb-1215

Key Players:

Allergen plc. (Abbvie), Novartis AG, Otsuka Pharmaceuticals Co., Ltd., Bausch Health Companies, Inc. Akron, Inc., Johnson & Johnson, Inc., Thea Pharmaceuticals Limited, OASIS Medical, Altaire Pharmaceuticals Inc., Boiron USA, Similasan Corporation, Scope Ophthalmics Ltd., Reckitt Benckiser Group PLC, Medicom Healthcare Ltd, FDC Limited., Lupin Limited, Jamjoom Pharmaceuticals Co., and Sentiss Pharma Private limited

Dry Eye Syndrome Treatment Market By Category

By Product:

Cyclosporine
Topical Corticosteroids
Artificial Tears
Punctal Plugs
- Removable
- Dissolvable
Oral Omega Supplements
Others

By Prescription:

Rx
OTC
Medical Device

By Distribution Channel:

Hospital Pharmacies
Eye Health Clinics
Retail Pharmacies
Online Pharmacies

Customization Available
https://www.futuremarketinsights.com/customization-available/rep-gb-1215

More Insights Into Dry Eye Syndrome Treatment Market

For a comprehensive understanding of the global market potential, growth, and scope, the market is segmented based on product type, prescription, distribution channel, and region. According to the same reports, based on segmentation, the Rx (prescription) medicine category held about 71.4% of the overall market share in 2021. In terms of distribution channels, the retail and hospital pharmacies segment will lead the market growth. Based on region, the Dry Eye Syndrome Treatment market in the US, Germany, and China will present impressive growth during the forecast period.

In this latest report, FMI offers a detailed and unbiased analysis of the global Dry Eye Syndrome Treatment market, providing historical data from 2016 to 2021 and forecast statistics for 2022 to 2032. The report highlights include a 9-year realistic sales prediction for the market, demand and supply trend analysis, illustrative representation of statistical data, and strategies adopted by leading players to retain a competitive edge.

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Forecasted Growth in Global Yogurt and Probiotic Drink Market: Projected Valuation of USD 209,660.3 Million by 2034

The global yogurt and probiotic drink market is likely to secure a valuation of US$ 197,014.2 million in 2024, with a CAGR of 7.6% during the forecast period. The global market is anticipated to capture a valuation of US$ 209,660.3 million by 2034.

Yogurt and probiotic drink producers are focused on premium products for healthy lifestyles for consumers, increasing the demand for yogurt and probiotic drinks. These manufacturers focus on consumers’ requirements for fit and non-alcoholic beverages, which are increasing the adoption of yogurt and probiotic drinks. Consumers are looking for gut health and better immune system products, and the adoption of yogurt drinks is expanding the market opportunities.

Request Your Sample Report Today: https://www.futuremarketinsights.com/reports/sample/rep-gb-18461

Manufacturers innovate cost-effective, natural, and high-quality drinks and are increasingly adopting yogurt and probiotic drinks. Consumers looking for fresh, organic, eco-friendly packaging solutions are increasing the demand for yogurt and probiotic drinks. Manufacturers offer lactose-free and organic ingredients drinks to improve consumers’ digestion and boost their energy.

Increasing advanced technology, infrastructure, and food sectors are rapidly fuelling the global market size. Food manufacturers add natural ingredients, plant-based additives, and natural flavours to attract consumers and enhance their sales volume. They are focused on offering no-sugar drinks for their consumers to maintain their diet plan and reduce toxicity.

Companies are looking for low-calorie, high-nutrient, and vitamin drinks to maintain their strength and energy, capturing consumers’ desire for yogurt and probiotic drinks. These manufacturers are enhancing their packaging style to catch consumers’ eye on their products. They advertise their products with simple and sustainable packaging, gaining vast popularity in the market.

Key Takeaways:

The yogurt and probiotic drink market is registering a CAGR of 7.6% between 2024 and 2034.
The United States is expected to register a CAGR of 6.3% by dominating the global market by 2034.
Germany is anticipated to capture a CAGR of 7.6% of the global market during the forecast period.
The United Kingdom is anticipated to register a CAGR of 8.9% in the global market in 2034.
China significantly drives the global market with a CAGR of 7%.
With a CAGR of 9.4%, India is rapidly advancing globally.
The yogurt drink category is estimated to lead the global market during the forecast period.

Maximize Growth Potential Grab Your Report Today: https://www.futuremarketinsights.com/checkout/18461

Competitive Landscape:

The global market is highly fragmented by present players that innovate cost-effective and high-quality products for their consumers to boost their health. They are heavily investing in research activities to develop unique texture drinks and beverages to maintain consumers’ immune systems. They are up surging the market to another height through various tactics and strategies.

Key players promote their products on exhibitions, festivals, trade shows, and online platforms to capture vast audiences. They are focused on consumer feedback and fill gaps according to their requirements. These players can solve their issues through better ideas and innovations to expand market opportunities. Key players are likely to build their goals in the coming period through their exotic flavor drinks and sustainable options.

Key Companies Profiled:

Danone
Yakult Honsha Co. Ltd
Grupo Lala
Chobani, LLC
Califia Farms
Harmless
Lifeway Foods, Inc
KeVita
Bio-K+

Key Segments Covered in the Yogurt and Probiotic Drink Market:

By Product Type:

Yogurt Drink
Juice
Water
Kefir
Others

By Source Type:

Dairy-based
Plant-based
Water-based

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

About Future Market Insights (FMI)

Middle East Veterinary Vaccines Market Is Expected to Grow at a 4% CAGR to Reach US$ 973.8 Million by 2033 | FMI

The Middle East Veterinary Vaccines Market is poised for significant growth, with a projected Compound Annual Growth Rate (CAGR) of 4% expected to hold steady until 2033. This positive outlook is driven by a surge in demand for veterinary vaccines across the region.

Market Value Expected to Nearly Double by 2033

The market size for veterinary vaccines in the Middle East is estimated at a robust US$627.1 million in 2023. This figure is anticipated to skyrocket to a staggering US$973.8 million by 2033, reflecting a near-doubling in market value within a decade.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-ma-3086

The rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This will fuel the demand for effective vaccination of livestock, especially in major animal farming and meat-producing nations in the region with a diversified herd such as Sudan, Turkey, Egypt, and KSA.

Rising per capita disposable income levels are largely contributing to the demand for processed food items. This is expected to drive the growth of veterinary vaccines in poultry and livestock segments.

The key players in the veterinary vaccine industry are focusing on finding innovative products to control zoonotic infection rates. Along with this, various advancements in biotechnology are expected to create a favorable platform for the development of various veterinary vaccines in developing markets such as UAE, KSA, Turkey, and Jordan. These techniques include next-generation sequencing, synthetic biology, and systems biology, among others.

Further, continued investments in multi-disciplinary vaccinology research could improve vaccine development efficiency and shorten the time-to-market for upcoming veterinary vaccines.

Key players are working on innovative products, conducting acquisitions, mergers, and agreements with other companies to improve their market presence and tap into less competitive emerging markets.

For instance, In September 2018, Boehringer Ingelheim announced that they would be donating 75,000 doses of rabies vaccines to the Global Alliance for Rabies Control, as an effort to recognize World Rabies Day on September 28^th.

Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level and help companies to sustain the increasing competitive pressure.

Key Takeaways from the Middle East Veterinary Vaccines Market Study

The attenuated live vaccines accounted for a 35.1% share of the total market of veterinary vaccines in the Middle East in 2021. The demand for attenuated live vaccines is expected to grow at a CAGR of 5.8% over the forecast period. By triggering a wide spectrum of immune responses, attenuated vaccines can deliver better immunity than conventional vaccinations.
The Livestock animals held the maximum share of 73.9% of the total veterinary vaccines market in terms of animals in 2021. Increased demand for processed meat products and making animal health a critical component of disease control is leading to increasing adoption of livestock animal vaccination in the Middle Eastern region.
The foot and mouth disease accounted for more than 27% of the market share of the Middle East veterinary vaccines market in 2021. Foot and mouth disease is the most commonly occurring disease among all the animals. This segment is expected to project a cumulative CAGR of 5.6% over the forecast period.
The private veterinary pharmacies registered sales worth U.S. $ 114.6 Mn during the year 2021 and are expected to project a cumulative CAGR of 5.0% over the forecast period. Increased awareness regarding animal vaccinations, rising incidences of foot and mouth disease, and high demand for good quality processed meat are some of the factors contributing to the growth of private veterinary pharmacies in the Middle East.

“Increased demand for processed meat products around the world will drive the demand for veterinary vaccines market in the Middle East,” says the FMI Analyst.

Who is winning?

The key manufacturers of the veterinary vaccines market are adopting strategies such as partnership strategies for global expansion and improving their hold over the global market.

In January 2021, Merck Animal Health announced the acquisition of Poultry Sense Ltd, which provides health and environmental monitoring solutions for the poultry industry.
In September 2019, Ceva, in partnership with Biotecon Diagnostics, announced the launch of their latest product, a real-time diagnostic kit that will help poultry producers fight salmonella infections in their farms.

The key players of the Middle East Veterinary Vaccines Market include :

JOVA, Bioveta, Inc., Intervac Pvt. Ltd., Zoetis, Elanco, Merial, Merck & Co. Inc, Bayer Pharma AG, Ceva and Boehringer Ingelheim.

Want more insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The Middle East veterinary vaccines market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights into the Middle East veterinary vaccines market. The veterinary vaccines market is segmented into five parts based on vaccine type (attenuated live vaccines, inactivated vaccines, toxoid vaccines, DNA vaccines, recombinant vaccines, and others) based on animal type (companion animals, livestock animals, and equine) based on disease indication (foot and mouth disease, Newcastle disease, PPRS, canine parvovirus, brucellosis, avian influenza, and others), based on end-user (hospital pharmacies, veterinary clinics, private veterinary pharmacies and others) and based on country ( KSA, UAE, Turkey, Jordan, Sudan, Egypt and Rest of MEA).

Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/3086

Middle East Veterinary Vaccines, by Category

By Vaccine:

Attenuated Live Vaccines
Inactivated Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Others

By Animal:

Companion Animals
- Canine
- Avian
- Feline
Livestock Animals
- Aquatic
- Bovine
- Porcine
- Small Ruminant
- Poultry
Equine

By Disease Indication:

Foot and Mouth Disease
Newcastle Disease
PPRS
Canine Parvovirus
Brucellosis
Avian Influenza
Others

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Branded Generics Market Is Expected to Grow at an Amazing 8.6% CAGR and Reach US$ 747.2 Million by 2033 | FMI

The Branded Generics Market is on the cusp of a significant upswing, with a projected market value of US$747.2 million by 2033. This impressive growth, fueled by a CAGR of 8.6%, signifies a near doubling of the market size from its estimated value of US$327.8 million in 2023.

Since branded generics are free from patenting, companies are investing handsome amounts in this drug category. The market is set to reach a valuation of around 283.2 Bn in 2021, with top players in tier-1 accounting for 20%-25% market share.

Request a Sample of this Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-1260

The entry of new players, simple market authorization procedures, greater profit margin and off-invoice discounts will expand the Global Branded Generics Industry during the forecast period.

As per the FMI’s analysis, despite the slight setback due to the pandemic, the Global Branded Generics Industry registered year-on-year (Y-o-Y) growth at 4.9% CAGR during 2020-2021.

“Rising demand for branded generics across both developing and developed economies along with high penetration of pharmaceutical industry will offer lucrative growth opportunities for the branded generics manufacturers during the forecast period” says the FMI analyst.

Key Takeaways from FMI’s Branded Generics Market Study

China and India are spearheading the growth of the Asia Pacific market spurred by the increasing adoption of branded generics by large-scale pharmacy chains in the emerging economies
The U.S. will lead North America’s branded generics market, registering a growth at 3.83% CAGR during the forecast period.
The market in India is expected to offer lucrative growth opportunities to branded generics manufacturers backed by the expansion of the pharmaceutical industry
In terms of therapeutic application, cardiovascular diseases, and diabetes are expected to account for a considerable market share
Oral solid-dose pharmaceutical formulation continues to be highly preferred among patients. The oral segment accounts for over 55% share of the global branded generics market.

Branded Generics Market Competitive Landscape

Teva, Abbott Laboratories, Novartis, Mylan, and Pfizer are some prominent players operating in the Global Branded Generics Industry cumulatively holding around 20-25% market share.

Key players operating in the branded generic market are focusing on expanding their business in emerging markets. They are adopting various organic and inorganic growth strategies such as mergers and acquisitions, advanced product development, and collaborations to gain a competitive edge in the market.

In October 2020, Glenmark Pharmaceuticals introduced NINDANIB (Nintedanib) for the treatment of pulmonary fibrosis in India. Glenmark has been amongst the first to launch the branded generic version at an affordable cost for the treatment of pulmonary fibrosis in India.

Branded Generics Market by Category Therapeutic Application:

Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
Dermatology Diseases
Analgesics and Anti-inflammatory
Others

Drug Class:

Alkylating Agents
Antimetabolites
Hormones
Anti-Hypertensive
Lipid Lowering Drugs
Anti-Depressants
Anti-Psychotics
Anti-Epileptics
Others

Formulation Type:

Oral
Parenteral
Topical
Others

Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/1260

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Insights into Global Rosmarinic Acid Market Growth: Forecasted Sales Increase to USD 309.56 Million by 2033 at 9.1% CAGR

According to Future Market Insights (FMI), the global rosmarinic acid market is presently valued at US$ 130.0 million in 2023. It is further poised to thrive at a CAGR of 9.1% during the forecast period 2023 to 2033. By 2033, total market size is projected to reach US$ 309.6 million.

Globally, the rosmarinic acid market is expanding at a rapid pace. This is attributable to an increase in applications across a variety of industries.

Rosmarinic acid is a polyphenolic chemical found naturally in herbs like rosemary, basil, and sage. It has antioxidant qualities and may have numerous health benefits.

Rosmarinic acid has also shown encouraging results as a feed supplement in boosting growth, reproductive performance, fertility, anti-oxidant status, and immunologic indices in animals. As a result, it is increasingly being employed in animal feed applications, which is expected to drive the market.

Request Your Sample Report Today: https://www.futuremarketinsights.com/reports/sample/rep-gb-17844

With increasing consumer interest in natural ingredients with potential health benefits, the rosmarinic acid industry is expected to witness sustained growth across multiple sectors including food, healthcare, and personal care.

The antioxidant qualities of rosmarinic acid make it an excellent choice for skincare products. Because of its antioxidant and anti-inflammatory characteristics, it can help battle oxidative stress, protect against environmental damage, and soothe irritated or sensitive skin.

Rosmarinic acid has beneficial effects on conditions such as allergies, inflammation-related diseases, and skin disorders. As a result, it is being widely used in dietary supplements or incorporated into pharmaceutical formulations.

Rosmarinic acid has also demonstrated excellent results as a feed addition in improving animal growth, reproductive performance, fertility, anti-oxidant status, and immunologic indices. As a result, it is increasingly being used in animal feed applications, which is expected to drive the market.

Key Takeaways from the Rosmarinic Acid Market Report:

The global rosmarinic acid market is expected to reach a market valuation of US$ 129.2 million by the end of 2033.
By application, food & beverages segment is predicted to reach a valuation of US$ 22.6 million in 2023.
The United States rosmarinic acid industry is projected to attain a valuation of US$ 102.4 million by 2033.
China market is anticipated to reach a valuation of US$ 17.2 million by 2033.
Rosmarinic acid demand in India is estimated to rise at a CAGR of 10.4% during the prediction period.

Who is Winning?

Naturex (part of Givaudan), Kalsec Inc., Nutra Green Biotechnology Co., Ltd., Layn Natural Ingredients Corp., Hunan E.K Herb Co., Ltd, Monteloeder, Kingherbs Limited, Hunan Nutramax Inc., Changsha Vigorous-Tech Co., Ltd., Shaanxi Yi An Biological Technology Co., Ltd, Blue California, and others are the few leading players operating in the market.

Investments in research & development, acquisitions, and mergers are beneficial strategies for companies in terms of improving their product quality and expanding their market reach. This is because combining resources, expertise, and customer base can lead to access to new technology, distribution channels, manufacturing facilities, and talent.

Similarly, launching new products can help businesses stay competitive and meet the changing consumer demands, allowing them to attract new customers and retain existing ones while increasing their market share. For instance,

In 2020, Blue California and biotech developer Conagen commercialized Rosavel®, a next-generation natural preservation solution with 98% high-purity rosmarinic acid.

Key Companies Profiled

Naturex (part of Givaudan)
Kalsec Inc.
Nutra Green Biotechnology Co., Ltd.
Layn Natural Ingredients Corp.
Blue California
Hunan E.K Herb Co., Ltd
Monteloeder
Kingherbs Limited
Hunan Nutramax Inc.
Changsha Vigorous-Tech Co., Ltd.
Shaanxi Yi An Biological Technology Co., Ltd

Maximize Growth Potential Grab Your Report Today: https://www.futuremarketinsights.com/checkout/17844

Rosmarinic Acid Market by Category

By Product Type:

>96% Purity
<=97% Purity

By Form:

Powder
Liquid

By Application:

Food and Beverage
Pharmaceuticals
Nutraceuticals
Cosmetics & Personal Care
Animal Feed

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

About Future Market Insights (FMI)

RTD Cocktail Shots Market to Surpass USD 9.6 Billion as Demand for Ready-to-Drink and Fresh Drinks is Surging | FMI

According to Future Market Insights (FMI), the demand for RTD cocktail shots is expected to surge with growing consumption of cocktails and preference for fresh products. Hence, key playera are trying to capitalize on the trend by presenting a classic cocktail in a container made with natural ingredients.

Further, sales of ready-to-drink cocktail shots are also burgeoning as they do not require preparation. Also, availability of high-quality ready-to-drink cocktail shots are proving to be a turnkey solution that saves time and money.

In terms of packaging, the cans segment is expected to dominate the RTD cocktail host market. Millennials and several craft brew enthusiasts prefer cocktail from a can, improving the demand for canned RTD cocktail shots.

Request Sample Report and Drive Impactful Decisions: https://www.futuremarketinsights.com/reports/sample/rep-gb-14680

Key Takeaways from Market Study

The ready-to-drink cocktail shots market is expected to expand at CAGR of 10.0% over the forecast period.
Among the type, spirit based is expected to dominate the market, accounting for 42.0% of the revenue during the forecast period.
Among the packaging segment, bottle segment accounted for more than 57.0% revenue share and it is expected to grow at 8.2% CAGR over the forecast period.
Among distribution channel segment, supermarkets/hypermarkets category will account for over 70% of demand share between 2022 and 2032.

“Ease in convenience coupled with busy lifestyle has increased the demand for ready-to-drink cocktail shots. Hence, key players are introducing fresh flavors to capitalize on growing demand,” says a Future Market Insights analyst.

Competitive Landscape

Key manufacturers of global ready-to-drink cocktail shots market are focusing on research & development in order to develop innovative and unique product offering. In addition to this, these key players in the ready-to-drink cocktail shots market are also concentrating on merger, acquisition and joint ventures to expand their geographical presence and to increase the existing production capacity.

In 2018, Bacardi Ltd announced the completion of its acquisition of PATRON brand of Patron Spirits International AG, the world’s best-selling ultra-tequila. With this acquisition, Bacardi becomes the leading spirits company in the ultra-segment in the United States, as well as the second largest in terms of market share by value.
In 2020, Bacardi Ltd, the world’s largest family-owned spirits company, announced the acquisition of batched cocktail and premium crafted company TAILS.

Gain Immediate Access to Detailed Market Insights Purchase Now: https://www.futuremarketinsights.com/checkout/14680

Explore More Valuable Insights

Future Market Insights, in its new report, offers an impartial analysis of the global ready-to-drink cocktail shots market, presenting historical data (2017-2021) and estimation statistics for the forecast period of 2022-2032.

The study offers compelling insights based on type (Malt-based, Wine-based, Spirit-based), by Packaging (Bottles, Can), by Distribution Channel (Online, Hypermarkets/supermarkets, Liquor Stores) across seven major regions of the world.

About Future Market Insights (FMI)

Contact FMI:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Urinary Tract Infection (UTI) Treatment Market is Expected to Grow Impressively, with a 1.9% CAGR to Reach US$ 13,617.4 Million by 2034 | FMI

The Urinary Tract Infection (UTI) Treatment Market is poised for steady growth, reaching an estimated US$13.617.4 million by 2034. This projection comes after a valuation of US$11,244.0 million in 2024. The market is expected to see a consistent increase with a Compound Annual Growth Rate (CAGR) of 1.9% between 2024 and 2034.

The urinary tract infection treatment market is poised for substantial growth in the foreseeable future, attributed to factors such as hormonal changes, inadequate personal hygiene practices, catheter usage, and other contributing factors. As the prevalence of urinary tract infections rises, the market is anticipated to experience noteworthy expansion in the coming years.

The heightened occurrence of chronic kidney diseases, including conditions like bladder cancer and renal failure, has resulted in a greater utilization of catheters and other drainage devices among patients. Individuals using urinary catheters face an elevated risk of developing complicated urinary tract infections, driving the demand for UTI treatment.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-1340

Supportive government policies, initiatives, and regulations can influence the market positively by fostering research and development in the field of UTI treatment. Increased spending on healthcare infrastructure and services, both in developed and developing countries, can positively influence the UTI treatment market.

The adoption of telehealth and remote patient monitoring technologies can facilitate better management and follow-up care for individuals with UTIs. Growing awareness among patients and healthcare professionals about the importance of early detection and prompt treatment of UTIs can contribute to market growth.

Urinary Tract Infection (UTI) Treatment Market Key Takeaways

From 2019 to 2023, the urinary tract infection (UTI) treatment market was valued at a CAGR of 2.1%
Based on indication, the uncomplicated UTI segment is expected to account for a share of 76.2% in 2024.
Global urinary tract infection (UTI) treatment demand in China is predicted to account for a CAGR of 2.0% in 2024.
In the United States, the urinary tract infection (UTI) treatment industry is expected to account for a CAGR of 2.5% in 2024.
India is projected to expand by a value CAGR of 1.9% between 2024 and 2034.
The urinary tract infection (UTI) treatment market in Japan is anticipated to record a CAGR of 2.1% in 2024.

“Increased prevalence of urinary tract infections and strategic advancements in treatment options propel the growth of the urinary tract infection treatment market.” says an FMI analyst.

Urinary Tract Infection (UTI) Treatment Market Competitive Landscape

The market players are investing in ongoing research and development activities to discover and develop new and more effective UTI treatment options. This could involve the exploration of novel antibiotics, combination therapies, and innovative drug delivery methods. Expanding market presence by entering new geographic regions and enhancing distribution networks to ensure wider availability of UTI treatments.

Bristol-Myers Squibb Company focuses on the development of drugs in various therapeutic areas, including infectious diseases. They might have products related to UTI treatment.
Janssen Global Services LLC is a pharmaceutical company under the umbrella of Johnson & Johnson. They may have products related to infectious diseases, including UTI treatment.
Lupin is an Indian multinational pharmaceutical company. They might have a range of pharmaceutical products, including those related to infectious diseases.

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the global urinary tract infection (UTI) treatment market, providing historical data from 2019 to 2023 and forecast statistics between 2024 and 2034.

To understand opportunities in the urinary tract infection (UTI) treatment industry, the industry is segmented based on Drug Class (Penicillin & Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides (Sulfamethoxazole, Trimethoprim), Azoles and Amphotericin B, Tetracycline (Doxycycline), Nitrofurans (Nitrofurantoin), Others) By Indication(Complicated Urinary Tract Infection, Uncomplicated Urinary Tract Infection) By Distribution Channel(Hospital Pharmacies, Gynecology and Urology Clinics, Drug Stores, Retail Pharmacies, Online Drug Stores) Region (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and the Middle East and Africa).

Key Players operating in the Urinary Tract Infection (UTI) Treatment Market are

Allergan
Bayer AG
Pfizer, Inc.
GlaxoSmithKline plc
Bristol-Myers Squibb Company
Janssen Global Services, LLC
Lupin Ltd
Merck & Co., Inc.
Almirall, S.A
Dr. Reddy’s Laboratories Ltd.

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/1340

Urinary Tract Infection (UTI) Treatment Market – Key Segments

By Drug Class:

Penicillin & Combinations
Quinolones
Cephalosporin
Aminoglycoside Antibiotics
Sulphonamides (Sulfamethoxazole, Trimethoprim)
Azoles and Amphotericin B
Tetracycline (Doxycycline)
Nitrofurans (Nitrofurantoin)
Others

By Indication:

Complicated
Uncomplicated

By Distribution Channel:

Hospital Pharmacies
Gynecology and Urology Clinics
Drug Stores
Retail Pharmacies
Online Drug Stores

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa

About the Healthcare Division at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations to provide authentic insights and accurate results to help clients worldwide.

With a repertoire of over 100+ reports and 1 billion+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Insights into the Expansion of Crab Meat Market Sales: Expected CAGR of 4.7%, Targeting USD 1,516.1 Million by 2033

The global Crab Meat Market estimated to reach US$ 879.2 million in 2023. The market is anticipated to expand at a CAGR of 4.7% during the forecast period 2023 to 2033. It is likely to reach a value of US$ 1,516.1 million by 2033.

The global crab meat market is a dynamic and thriving segment within the seafood business. Crab meat is known for its distinct flavor and versatility in various culinary preparations, due to which it has gained significant popularity worldwide.

The market is driven by several crucial factors. This includes increasing consumer awareness of the nutritional benefits associated with seafood consumption and changing dietary preferences towards healthier protein options.

Request Your Sample Report Today: https://www.futuremarketinsights.com/reports/sample/rep-gb-17867

Sustainability has also become a key focus. Consumers now demand responsibly sourced crab meat that aligns with ethical and environmental considerations.

Europe and the United States are prominent regions fueling the demand for crab meat, given their culinary traditions and appreciation for high-quality ingredients. Europe has a diverse food culture, particularly in countries such as France, Spain, Italy, and the United Kingdom. These countries contribute to a strong affinity towards seafood delicacies such as crabs.

Consumers are increasingly seeking higher-quality crab meat to enhance their dining experiences, leading to a demand for premium crab meat options. Specialty crab meat is often perceived as a healthy protein option, rich in nutrients and low in fat. It will likely drive health-conscious consumers to choose these varieties.

The demand for unique flavors and culinary experiences has led to an increased interest in specialty crab meat varieties, which can offer distinct tastes and textures. Upscale restaurants and hotels are incorporating premium crab meat varieties into their menus. This helps cater to discerning customers and contributes to market growth.

Specialty crab meat is often associated with special occasions and celebrations, leading to increased demand during festive seasons and events. As culinary boundaries blur, consumers are more open to trying international dishes that feature specialty crab meat. This is a key factor driving demand for diverse crab meat options.

The rise of online shopping and food delivery platforms has made it easy for consumers to access and order premium crab meat varieties, boosting market demand. Consumers are increasingly concerned about sustainability and ethical sourcing, leading to a preference for premium crab meat that is sourced responsibly.

The convenience-driven lifestyle of modern consumers has led to an increased demand for value-added products such as pre-packaged meals or ready-to-eat snacks that offer quick preparation times without compromising quality or taste.

Technological advancements have also played a vital role in maintaining product freshness during processing and extending shelf life through improved packaging techniques and efficient cold-chain logistics.

Key Takeaways from this Market Report:

The global sales of crab meat are expected to reach a valuation of US$ 1,516.1 million by the end of 2033.
Sales in the crab meat market are anticipated to expand at a CAGR of 4.7% over the forecast period.
The United States is projected to have a valuation of US$ 580.7 million by 2033 in the crab meat industry globally.
Germany is projected to reach a market valuation of US$ 350.2 million by 2033.
India is estimated to have a value CAGR of 5.6% during the forecast period 2023 to 2033.

Maximize Growth Potential Grab Your Report Today: https://www.futuremarketinsights.com/checkout/17867

Who is Winning?

Key manufacturers are ensuring high quality and food safety standards through rigorous testing, certifications, and traceability systems. It is a key strategy to build consumer trust and meet regulatory requirements. Manufacturers are investing in innovative packaging solutions to extend shelf life, maintain product freshness, and enhance convenience for consumers.

Key manufacturers are collaborating with retailers, distributors, and restaurant chains, as they can help manufacturers increase their distribution reach and access a wide customer base. They are investing in research and development to create new crab meat-based products, flavors, and formulations. It can keep manufacturers competitive and appealing to changing consumer tastes.

They are launching new products, which are essential in helping businesses stay competitive and meet changing consumer demands. This is allowing them to attract new customers and retain existing ones while increasing their market share.

Key Companies Profiled in the Crab Meat Market are:

Phillips Foods, Inc.
Blue Star Foods Corp.
Handy International Incorporated.
Red Chamber Co., Ltd.
Trans-Ocean Products Inc.
Crown Prince, Inc.
Chicken of the Sea International.
East Coast Seafood Group.
Thai Union Group PCL.
Nissui Group.

Key Players in the Market:

Phillips Foods, Inc. offers a variety of seafood products, with a focus on crab and other seafood items. A few of their popular offerings include crab cakes, crab meat, shrimp, and other seafood-based dishes. They provide both retail products for consumers and food service products for restaurants and other businesses in the food industry.
Blue Star Foods Corp. is a Miami-based worldwide seafood enterprise. It imports, packages, and distributes chilled pasteurized crab flesh and other high-quality seafood.

Market Outlook by Categorization:

By Product Type:

Lump Crab Meat
Claw Crab Meat
Backfin Crab Meat

By Form:

Fresh Crab Meat
Pasteurized/Canned Crab Meat
Frozen Crab Meat

By Sales Channel:

Foodservice (HoReCa)
Retail
- Supermarkets
- Hypermarkets
- Convenience Stores
- Specialty Seafood Stores
- Online Retailers

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

About Future Market Insights (FMI)

Empty Capsules Market Set to Reach USD6.4 Billion by 2034, with a healthy CAGR 8% | FMI Study

The Empty Capsules Market is experiencing a surge in growth, driven by increasing demand in the pharmaceutical and nutraceutical industries. According to a recent report, the global market is expected to reach a staggering US$6.378.6 million by 2034. This signifies a substantial rise from the projected market size of US$2,956.6 million in 2024, reflecting a healthy Compound Annual Growth Rate (CAGR) of 8%.

Driving Factors Behind Surging Demand for Empty Capsules

The primary drivers behind the surging demand for empty capsules are twofold. First, there is a noticeable uptick in the popularity of capsules as the preferred form of drug delivery. This shift is further accentuated by the increasing consumption of various medications. Secondly, as the global burden of chronic diseases continues to escalate, the demand for effective therapeutics is expected to surge, presenting lucrative opportunities for suppliers of empty capsules.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-782

The Advantages of Capsule-Based Drug Delivery Systems

Moreover, the shift towards capsule-based drug delivery systems can be attributed to their several advantages, including improved bioavailability, better patient compliance, and enhanced efficacy. These benefits have significantly contributed to the growing preference for capsules among both patients and healthcare professionals. As a result, the demand for empty capsules is on a continuous rise.

A Promising Future for the Empty Capsules Market

In summary, the future of the Global Empty Capsules Industry appears incredibly promising, with robust growth prospects anticipated in the years ahead. Key industry players operating in the market are well-positioned to benefit from this trend, provided they adapt to evolving consumer preferences and invest in product innovation to maintain a competitive edge.

Empty capsules are known as protective shells for drugs designed from special film-forming materials such as gelatin, starch, and pullulan. Being innovative drug delivery products, they are utilized by leading pharmaceutical and biopharmaceutical companies due to their various attractive features. Such capsules are economical, oxidation resistant, offer maximum flexibility, and are easy to use on account of their smooth and slippery nature. Furthermore, they are especially suitable for substances having a bitter taste and unpleasant odor.

Empty Capsules Market Key Takeaways

With a market share of more than 38.3%, North America now dominates the global empty capsules industry.
Western Europe and Eastern Europe currently have market shares of more than 18.8% and 7.8%, respectively.
Latin America is expected to develop significantly throughout the projected period, accounting for more than 9.7% of the Global Empty Capsules Industry.
The German empty capsules market is committed to the region’s growth. The German market is expected to reach US$ 269.6 million by 2033, growing at a CAGR of 7.9% in the interim.
Gelatin-based capsules, particularly 00 gelatin capsules, 000 gelatin capsules, size 5 gelatin capsules, and size 3 gelatin capsules, are expected to grow in popularity until 2033.
In recent years, there has been a significant growth in the consumption of nutraceuticals to strengthen immunity and compensate for the nutrition lost owing to poor eating habits and the irregularity of a sedentary lifestyle.

Empty Capsules Market Competitive Landscape

The Global Empty Capsules Industry is known to be highly competitive in nature attributed to the presence of leading empty pill manufacturers that account for over 70% of the global market share. Prominent market players are constantly focusing on introducing new products designed out of innovative materials. In addition to that, they are adopting growth strategies such as partnerships, mergers, acquisitions, etc. to expand their global footprint.

List encompassing key players operating in the Empty Capsules Market

ACG Worldwide
Capsugel
Qualicaps Inc.
Bright Pharma Caps Inc.
Sunil Healthcare Ltd.
CapsCanada Corporation
Roxlor LLC
Snail Pharma Industry Co. Ltd.
Suheung Co. Ltd.
Medi-Caps Ltd

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/782

Key Segments of Empty Capsules Market Survey

Capsule Size:

Size “000” Empty Capsules
Size “00” Empty Capsules
Size “0” Empty Capsules
Size “1” Empty Capsules
Size “2” Empty Capsules
Size “3” Empty Capsules
Size “4” Empty Capsules
Size “5” Empty Capsules

Product Type:

Gelatin (Hard)-based Capsules
Vegetarian-based Capsules

Route of Administration:

Empty Capsules for Oral Administration
Empty Capsules for Inhalation

Raw Material:

Contract Type-A (Pork Skin) Empty Capsules
Type-B Gelatin (Animal Bones & Calf Skin) Empty Capsules
Fish Bone Gelatin Empty Capsules
Empty Hydroxy Propyl Methyl Cellulose (HPMC) Empty Capsules
Starch Material Empty Capsules
Empty Pullulan Capsules

End User:

Empty Capsules for Pharmaceutical Companies
Empty Capsules for Cosmetic & Nutraceutical Companies
Empty Capsules for Clinical Research Organizations (CROS)

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us: